MacuLogix Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 70
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $22M
Latest Deal Amount
  • Investors
  • 10

MacuLogix General Information

Description

Developer of optical testing equipment designed to increase early detection of age-related macular degeneration. The company's testing equipment uses a dark adaptometer that engages in the detection of progressive eye diseases that leads to macular degeneration, enabling eye care specialists to intervene as early as possible and maintain a patient's quality of life with proactive intervention.

Contact Information

Formerly Known As
Apeliotus Vision Science
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 3721 TecPort Drive
  • Suite 301
  • Harrisburg, PA 17111
  • United States
+1 (717) 000-0000

MacuLogix Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MacuLogix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 14-Dec-2021 $22M 00000 Completed Generating Revenue
9. Later Stage VC (Series E) 10-Nov-2020 0000 000.00 0000 Completed Generating Revenue
8. Debt - PPP 12-Apr-2020 00.000 000.00 Completed Generating Revenue
7. Debt - General 30-Sep-2019 000.00 Completed Generating Revenue
6. Later Stage VC (Series D) 04-Mar-2019 000.00 000.00 000.00 Completed Generating Revenue
5. Debt - General 20-Jul-2018 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 31-Jul-2015 000 000.00 0000 Completed Generating Revenue
3. Later Stage VC (Series B) 05-Jun-2014 00.00 00.00 000.00 Completed Generating Revenue
2. Later Stage VC (Series A) 11-Mar-2013 $3.6M $3.6M 00.00 Completed Generating Revenue
1. Grant 05-Nov-2009 $25K Completed Startup
To view MacuLogix’s complete valuation and funding history, request access »

MacuLogix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series D 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series C 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series B 2,056,838 $0.000100 8% $1.98 $1.98 1x $1.98 3.84%
Series A 1,690,198 $0.000100 8% $2.32 $2.32 1x $2.32 3.16%
To view MacuLogix’s complete cap table history, request access »

MacuLogix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of optical testing equipment designed to increase early detection of age-related macular degeneration. The com
Diagnostic Equipment
Harrisburg, PA
70 As of 2021
00000
0000000000 0 00000

000000

aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea co
0000000000 000000000
Los Angeles, CA
00 As of 0000
000.00
00000 00000

0000000

esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in
0000000000 000000000
Coralville, IA
00 As of 0000
0000
000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MacuLogix Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eyenuk Venture Capital-Backed Los Angeles, CA 00 000.00 00000 00000
0000000 0000000000 Venture Capital-Backed Coralville, IA 00 0000 000000 0 0000
000000000 Formerly VC-backed Coimbra, Portugal 0 00000 000000&0 00000
You’re viewing 3 of 3 competitors. Get the full list »

MacuLogix Patents

MacuLogix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200093362-A1 Method and apparatus for guiding a test subject through an ophthalmic test Granted 21-Sep-2018 00000000 0
EP-3852605-A1 Methods, apparatus, and systems for ophthalmic testing and measurement Pending 21-Sep-2018 000000000
US-20200093361-A1 Methods, apparatus, and systems for ophthalmic testing and measurement Granted 21-Sep-2018 000000000 0
US-11089954-B2 Method and apparatus for guiding a test subject through an ophthalmic test Active 21-Sep-2018 000000000 000
CA-3113658-A1 Methods, apparatus, and systems for ophthalmic testing and measurement Pending 21-Sep-2018 A61B3/063
To view MacuLogix’s complete patent history, request access »

MacuLogix Executive Team (14)

Name Title Board Seat Contact Info
William McPhee Chief Executive Officer, President & Board Member
Gregory Jackson Ph.D Co-Founder, Chief Technology Officer & Board Member
Olga Georgievová Senior Manager of Global Marketing
Daniel Dorsey Senior Vice President, Finance
Dave Miller Senior Vice President, Marketing
You’re viewing 5 of 14 executive team members. Get the full list »

MacuLogix Board Members (9)

Name Representing Role Since
Carole Nuechterlein JD Roche Venture Fund Board Member 000 0000
Gregory Jackson Ph.D MacuLogix Co-Founder, Chief Technology Officer & Board Member 000 0000
Jack Nielsen Vivo Capital Board Member 000 0000
Nathan Dau JD Vivo Capital Board Member 000 0000
Ronald Thiboutot Ph.D Life Sciences Greenhouse of Central Pennsylvania Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

MacuLogix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MacuLogix Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
New Harbor Venture Partners Growth/Expansion Minority 000 0000 000000 0
Pam Martin Angel (individual) Minority 000 0000 000000 0
Vivo Capital Venture Capital Minority 000 0000 000000 0
Horizon Technology Finance BDC Lender/Debt Provider Minority 000 0000 000000 0
Fisk Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »